Showing results (71-80 of 291) with videos related to
Sort By:
Pageof 30
Clinical and Experimental Immunology|November 1, 1977
The activation of the C3b feedback cycle with human complement components. I. Through the classical pathwayL W Mak, P J Lachmann, J MajewskiClinical and Experimental Immunology|November 1, 1977
The activation of the C3b feedback cycle with human complement components. II. Using components of the alternative pathwayL W Mak, J Majewski, P J LachmannBiochemical and Biophysical Research Communications|October 16, 1989
A novel strategy for producing chimeric bispecific antibodies by gene transfectionS Songsivilai, P M Clissold, P J LachmannScandinavian Journal of Immunology|March 1, 1988
The killing of tumour cell targets coupled to tuberculin (PPD) by human and murine PPD-reactive T helper clones. I. PPD specificity of killingA Vyakarnam, P J Lachmann, D Y SiaClinical and Experimental Immunology|March 1, 1983
Further studies of the C3g component of the alpha 2D fragment of human C3H Chaplin, M C Monroe, P J LachmannBlood|October 1, 1985
Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1G D Ross, R A Thompson, M J Walport, et al.European Journal of Immunology|September 1, 1993
Construction, expression and functional analysis of a glycolipid-linked form of CR1P M Clissold, H J Ebling, P J LachmannJournal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3bG D Ross, J A Cain, P J LachmannJournal of Immunology (Baltimore, Md. : 1950)|October 1, 1979
Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activationF Santoro, P J Lachmann, A Capron, et al.Immunology|February 1, 1992
The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugateA M Montgomery, M G Wing, P J LachmannPageof 30